MENU
简体中文
ENG
Home
About Us
Our Facilities
SPIRO Site
PINE Site
OBiO Intelli-M
Leadership Team
Laboratory Sciences
CDMO Solutions
Process Development
cGMP Manufacturing
Viral Vector
Oncolytic Virus
Cell Therapy Products
Plasmid & Nucleotides
Quality & Regulatory
Cold Chain Logistics
Innovations
Insights
Press Releases
Events
Knowledge Center
Investor Relations
Contact Us
Enable Gene Therapy For Better Lives
Your Trustful Partner in Research and Manufacturing for Gene and Cell Therapy
Make Gene Delivery Accessible
Side-by-Side Navigation for Your Innovations
Industrialize Your Product At OBiO
End-to-End Offerings with Versatile Technical Platform
In China For Global Customers
OBiO Intelli-M with a 77,000 sqm GMP footprint will start operating in late 2022
Providing client-centered and high-quality service as our commitment, we strive to become a world leading gene and cell therapy CRO/CDMO group.
Our Offering
CDMO
Solutions
OBiO offers holistic solutions in process development, analytical method, IND-enabling CMC, clinical and commercial contract manufacturing of viral vector, oncolytic virus, and cell therapy products.
Laboratory
Sciences
OBiO provides an integrated portfolio of plasmid construction, viral packaging, cell biology and animal study services for biomedical researchers.
Our Facilities
SPIRO Site
Integrated Laboratory Services
Process and Analytical Method Development
Research and Development Center
International Medical Park Shanghai, China
OBiO Intelli-M
Process Development & Characterization
Clinical and Commercial Manufacturing
77,000-square-meter Facility for Global Supply
Lin-Gang Free-Trade Zone Shanghai, China
PINE Site
Process and Analytical Method Development
Pre-clinical and Clinical Manufacturing
Three-building, 10,000-square-meter campus
International Medical Park Shanghai, China
Insights
Press Releases
Events
May 03,2023
OBiO and CHINAGENE reached a strategic agreement of commercial manufacturing services for gene therapy products
On April 21, 2023, OBiO Technology (Shanghai) Corp., Ltd. (OBiO) announced a strategic agreement of commercial manufacturing collaboration with CHINAGENE.
Apr 27,2023
A new super factory with 29 GMP grade production lines for gene and cell therapy was launched in Shanghai by OBiO technology
On April 21, 2023, OBiO Technology (Shanghai) Corp., Ltd. ("OBiO" or "the Company"), a leading gene and cell therapy CDMO in China, announced the launching of a new GMP manufacturing base, named OBiO Intelli-M. The new base was located in the China (Shanghai) Pilot Free Trade Zone, Lin-Gang Special Area, with 29 production lines and 828,000+ square feet in area, which was one of the biggest super factories for gene therapy in the world.
Mar 31,2023
Congratulations to immvira’s for its malignant glioma oncolytic product approved
OBiO Techonoly congratulates Immvira that its oncolytic virus product MVR-C5252 targeting malignant glioma obtained the approval from National Medical Products Administration ("NMPA") for Phase I clinical trial in China.
ALL PRESS RELEASES
May 16-20, 2023
ASGCT 26TH ANNUAL MEETING
Los Angeles, CA
APR 15-16, 2022
SAPA-GP 2022 Annual Conference (Hybrid)
King of Prussia, PA
MAY 16-19, 2022
ASGCT 25TH ANNUAL MEETING
WASHINGTON, D.C.
ALL EVENTS
Contact Us
First Name*
Last Name*
Company*
Email*
Phone Number*
I'm interested in…
Please choose
General Inquiry
Laboratory Sciences
Process Development
Analytical/Formulation Development
Non-IND (IIT) Service
IND-Enabling CMC (IND-CMC) Service
Clinical Manufacturing
Commercial Manufacturing
Extended Services (Pre-IND/Post-IND)
Investor Relations
Questions or Comments
Security Code*
I AGREE*
By submitting this form I agree that OBiO may process my data in the manner described in OBiO’s
Privacy Policy
We won’t share your information.
Main
+86 400-151-5198
Tel
+1-408-807-5641
For General Inquiry
oobio@obiosh.com
For Business Inquiry
bd@obiosh.com
Address
446 S Hillview Dr Milpitas, CA 95035 U.S.A
About Us
Laboratory Services
Insights
Innovations
Investor Relations
CDMO Solutions
Process Development
cGMP Manufacturing
Quality & Regulatory
Cold Chain Logistics
Privacy Policy
© 2023 OBiO Technology (Shanghai) Corp., Ltd. All Rights Reserved